ID   GH364
AC   CVCL_K171
SY   GH-3-64
DR   ATCC; CRL-13004
DR   Wikidata; Q54835773
RX   Patent=US6365394;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3405.
CC   Population: African American.
CC   Characteristics: Transfected with plasmid constructs carrying a 3.4 kb DNA fragment of Ad 5 genome spanning 511 to 3924 bp (E1a and E1b open reading frames and part of the pIX gene) under the control of a phosphoglycerate kinase (PGK) promoter (Patent=US6365394).
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CRL-13004; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 17
//
RX   Patent=US6365394;
RA   Gao G.-P., Wilson J.M.;
RT   "Cell lines and constructs useful in production of E1-deleted
RT   adenoviruses in absence of replication competent adenovirus.";
RL   Patent number US6365394, 02-Apr-2002.
//